Physician profile
Donald E Buddecke
NPI 1699763938
$46,789.76
in general payments reported to CMS, 2019-2025
26 companies · $5,431 in 2025
The $5,431 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $2,976 · 2021: $241 · 2022: $13K · 2023: $5,295 · 2024: $6,508 · 2025: $5,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7,768 · Consulting Fee: $4,963 · Food and Beverage: $2,816 · Travel and Lodging: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,767.88 |
| Consulting Fee | $4,962.50 |
| Food and Beverage | $2,816.07 |
| Travel and Lodging | $1,687.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $27,556.91 | 2019-2022 | |
| Ortho Solutions INC | $13,888.10 | 2019-2025 | |
| Medshape, INC. | $1,621.73 | 2023-2024 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Stryker Corporation | $626.35 | 2019-2024 | Ortholoc 2 Lapifuse, Ortholoc 3di, Variax |
| Organogenesis INC. | $565.65 | 2019-2025 | Puraply, Via Matrix |
| Trilliant Surgical LLC. | $366.84 | 2023-2024 | Minimally Invasive Bunion Plate, Left, Arsenal Sinus Support Plate, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Novastep INC. | $324.77 | 2022-2023 | Peca Bunion Correction System |
| Smith+Nephew, INC. | $285.88 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $240.87 | 2019-2024 | |
| Conetic Solutions, INC. | $232.13 | 2020-2025 | |
| Depuy Synthes Sales INC. | $161.69 | 2021-2025 | Motoband, Minibunion, Na |
| Paratek Pharmaceuticals, INC. | $154.59 | 2022-2024 | Nuzyra |
| Biogennix, LLC | $126.34 | 2022 | |
| Djo, LLC | $108.60 | 2024-2025 | Cmf |
| Horizon Therapeutics Plc | $79.49 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $79.12 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $77.88 | 2023 | |
| Kerecis Limited | $55.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $47.62 | 2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $37.08 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $35.58 | 2022-2024 | Accelstim, Physio-Stim |
| Grt US Holding, INC. | $29.36 | 2022 | |
| Medtronic, INC. | $29.00 | 2023 | Intellis Adaptivestim |
| Hydrofera LLC | $27.17 | 2023 | Hydrofera Blue |
| Nevro Corp. | $19.01 | 2023 | Senza |
| Merck Sharp & Dohme LLC | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Buddecke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.